Cargando…
Characterization of vertigo and hearing loss in patients with Fabry disease
BACKGROUND: Fabry Disease (FD) is an X-linked hereditary lysosomal storage disorder which leads to a multisystemic intralysosomal accumulation of globotriaosylceramid (Gb3). Besides prominent renal and cardiac organ involvement, patients commonly complain about vestibulocochlear symptoms like high-f...
Autores principales: | Köping, Maria, Shehata-Dieler, Wafaa, Schneider, Dieter, Cebulla, Mario, Oder, Daniel, Müntze, Jonas, Nordbeck, Peter, Wanner, Christoph, Hagen, Rudolf, Schraven, Sebastian P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6094894/ https://www.ncbi.nlm.nih.gov/pubmed/30111353 http://dx.doi.org/10.1186/s13023-018-0882-7 |
Ejemplares similares
-
Cardiac and renal dysfunction is associated with progressive hearing loss in patients with Fabry disease
por: Köping, Maria, et al.
Publicado: (2017) -
Hot topics in Fabry disease
por: Cairns, Tereza, et al.
Publicado: (2018) -
Treatment of hypertrophic cardiomyopathy caused by cardiospecific variants of Fabry disease with chaperone therapy
por: Müntze, Jonas, et al.
Publicado: (2018) -
Association and diagnostic utility of diastolic dysfunction and myocardial fibrosis in patients with Fabry disease
por: Liu, Dan, et al.
Publicado: (2018) -
Oral Chaperone Therapy Migalastat for Treating Fabry Disease: Enzymatic Response and Serum Biomarker Changes After 1 Year
por: Müntze, Jonas, et al.
Publicado: (2019)